 |
 |
 |
 |
 |
 |
 |
|
|
|
|||||||||
|
|||||||||||
Research Articles |
OBJECTIVE: To document a case in which the administration of itraconazole was associated with an apparent decrease in digoxin clearance, resulting in an increase in the serum digoxin concentration. CASE SUMMARY: A man receiving digoxin for atrial fibrillation was concurrently treated with itraconazole 200 mg/d for esophageal candidiasis. The estimated urinary digoxin clearance was decreased during this combination therapy. DISCUSSION: Digoxin is primarily cleared by the kidneys, and the mechanism of renal clearance involves both glomerular filtration and tubular secretion. We postulate that itraconazole or a metabolite of this compound may have resulted in decreased tubular secretion of digoxin, accounting for decreased urinary digoxin clearance. CONCLUSIONS: Monitoring of serum digoxin concentrations should be performed if patients taking digoxin are treated with itraconazole. Further investigation is necessary to elucidate the nature of the interaction between digoxin and itraconazole.
This article has been cited by other articles:
|
|
 |
|
  M. Feuring, Y. Lee, L. H. Orlowski, N. Michiels, M. De Smet, A. K. Majumdar, K. J. Petty, M. R. Goldberg, M. G. Murphy, K. M. Gottesdiener, et al. Lack of Effect of Aprepitant on Digoxin Pharmacokinetics in Healthy Subjects J. Clin. Pharmacol., August 1, 2003; 43(8): 912 - 917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Angirasa and A. Z. Koch P-glycoprotein as the Mediator of Itraconazole-Digoxin Interaction J Am Podiatr Med Assoc, September 1, 2002; 92(8): 471 - 472. [Full Text] [PDF]
|
|
 |
 |
 |
 |
 |
 |
 |
